FDA Approves Noninvasive Optune Pax Device for Advanced Pancreatic Cancer

TUESDAY, Feb. 17, 2026-- The U.S. Food and Drug Administration has approved a first-of-its-kind, noninvasive device, the Optune Pax, for the treatment of adult patients with locally advanced pancreatic cancer.Optune Pax is a portable, noninvasive...